The authors describe the one-year results of a randomized trial comparing outcomes between transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) among an all-comers cohort of 280 patients.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Transcatheter
March 16, 2015
Using STS/ACC registry data, the authors updated 30-day outcomes and present 1 year outcomes for TAVR pts. Over 12,000 pts were in the registry; median age was 84, and STS predicted operative mortality risk was 7.1%. 30-day mortality was 7.0%, 1-year mortality was 23.7%. 1-year mortality was associated with advanced age, male sex, end-stage renal
March 6, 2015
This video demonstrates a transaortic approach for TAVR, through the second intercostal space. Illustrations, photos, 3D CAT scan images, and rotating fluoroscopic images are used to demonstrate this approach.
February 22, 2015
This manuscript reports on data from the UK registry from 2007 to 2012 including 3980 TAVI procedures and a 6 year follow up. The authors carry out a good analysis of trends, risk factors for mortality and results. They found little change in the characteristics of patients treated in the UK by TAVI from 2007 to 2012.
February 2, 2015
This manuscript describes the findings of a retrospective analysis of 874 consecutive high risk or inoperable patients undergoing TAVR in three different centres, evaluating outcomes after up to three years of follow up. In-hospital mortality was 5%. Early mortality was strongly associated with the occurrence of procedural complications.
January 25, 2015
This manuscript offers a comprehensive and easy to read review of annular rupture during TAVI. The authors explain the pathophysiology of this complication and classify it according to the anatomical location. They also discuss the management options in terms of diagnosis and treatment.
January 18, 2015
This a retrospective study of 175 patients who had survived more than 12 months following TAVI and for whom there were clinical and echocardiographic follow up data. Outcomes were compared between patients with significant (grade II or more) aortic regurgitation (AR) and those without significant aortic regurgitation (less than grade II).
January 16, 2015
Transcatheter aortic valve implantation has also evolved as a suitable treatment option for degenerative surgical heart valve disease, with considerable experience in the aortic and mitral positions. Success of a valve-in-valve (VIV) procedure depends on four main concepts. These include the following:
December 30, 2014
This is a retrospective review of 260 patients undergoing TAVI, looking at the relationship between aortic valve calcium score and post procedural paravalvular leakage. The results suggest that the amount of calcification significantly impacts the occurrence, the degree and localization of paravalvular leakage after TAVI.
December 28, 2014
This is a retrospective study comparing outcomes in 25 octogenarian patients undergoing percutaneous mitral valve intervention with the Mitraclip device and 35 octogenarian patients undergoing surgical mitral valve repair or replacement for isolated mitral regurgitation.